Lee Cronin's The Mummy, which hit theaters April 17 after a Los Angeles premiere on April 9, has garnered a mixed critical reception on Rotten Tomatoes, with the Tomatometer settling around 55-60% "rotten" from over 130 reviews praising its juicy gore, body horror visuals, and scares akin to Evil Dead Rise, while faulting a padded runtime, derivative plotting, and lack of emotional depth. Audience scores contrast sharply at 76-82%, the franchise's highest and outpacing Brendan Fraser's entries, signaling strong fan embrace of the R-rated reimagining from Blumhouse and Atomic Monster. Trader consensus reflects this divide, with scores unlikely to shift dramatically post-opening weekend's $13.5M domestic haul amid stiff competition; monitor late reviews through mid-May for final stabilization.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato"Lee Cronin's The Mummy" Rotten Tomatoes score?
"Lee Cronin's The Mummy" Rotten Tomatoes score?
$26,635 Vol.
25+
Sì
35+
Sì
45+
Sì
55+
No
60+
No
65+
No
70+
No
75+
No
80+
No
85+
No
$26,635 Vol.
25+
Sì
35+
Sì
45+
Sì
55+
No
60+
No
65+
No
70+
No
75+
No
80+
No
85+
No
If, for any reason, the resolution data is unavailable at this market's specified end time, the resolution source will be checked until the relevant data is available. This market will resolve to “No” if no data is available by April 24, 2026, 11:59 PM ET.
Mercato aperto: Apr 17, 2026, 4:18 PM ET
Resolver
0x65070BE91...Esito proposto: Sì
Nessuna contestazione
Esito finale: Sì
If, for any reason, the resolution data is unavailable at this market's specified end time, the resolution source will be checked until the relevant data is available. This market will resolve to “No” if no data is available by April 24, 2026, 11:59 PM ET.
Resolver
0x65070BE91...Esito proposto: Sì
Nessuna contestazione
Esito finale: Sì
Lee Cronin's The Mummy, which hit theaters April 17 after a Los Angeles premiere on April 9, has garnered a mixed critical reception on Rotten Tomatoes, with the Tomatometer settling around 55-60% "rotten" from over 130 reviews praising its juicy gore, body horror visuals, and scares akin to Evil Dead Rise, while faulting a padded runtime, derivative plotting, and lack of emotional depth. Audience scores contrast sharply at 76-82%, the franchise's highest and outpacing Brendan Fraser's entries, signaling strong fan embrace of the R-rated reimagining from Blumhouse and Atomic Monster. Trader consensus reflects this divide, with scores unlikely to shift dramatically post-opening weekend's $13.5M domestic haul amid stiff competition; monitor late reviews through mid-May for final stabilization.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti